http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-202192006-A1
Outgoing Links
| Predicate | Object |
|---|---|
| filingDate | 2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-202192006-A1 |
| titleOfInvention | HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS |
| abstract | Aminopyrazine compounds are presented as adenosine receptor modulators. The compounds may find use as therapeutic agents for the treatment of diseases mediated through the G-protein coupled receptor signaling pathway and may find particular use in oncology. |
| priorityDate | 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78747 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421355198 |
Total number of triples: 9.